Pharmaron Beijing (HKG:3759, SHE:300759) completed the issue of 2.18 billion yuan of USD-settled zero-coupon convertible bonds maturing in 2027 to raise net proceeds of $327.2 million.
The bonds are convertible into Hong Kong-listed Shares at HK$36.08 apiece, according to a Wednesday Hong Kong bourse filing.
The company will use proceeds for business expansion, development of its lab and CDMO services, refinancing of debt, general corporate purposes, and working capital.